The independent source for health policy research, polling, and news.
Elizabeth Lucas was the data editor at 窪蹋勛圖厙 News until August 2021.
Showing 21 - 32 of 32
The federal government has doled out at least $2.4 billion in state grants since 2017 to address the opioid epidemic, which killed 47,600 people in the U.S. that year alone. But local officials note that drug abuse problems seldom involve only one substance.
In its latest update to the Nursing Home Compare website, the government gave 1,638 homes its lowest star rating for staffing one star on its five-star scale. Most were downgraded because payroll records reported no registered-nurse hours at all for at least four days.
A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.
No one tracks sepsis cases closely enough to know how often these severe infections turn fatal. But the toll both human and financial is enormous, finds an investigation by KHN and the Chicago Tribune.
Medicare said those homes either lacked a registered nurse for a high number of days over three months, provided data the government couldnt verify or didnt supply their payroll data at all.
Denmark-based drugmaker Novo Nordisk has invested more in lobbying and doubled political donations since 2015.
Kaiser Health News launches Pre$cription for Power, a groundbreaking database to expose Big Pharmas ties to patient groups.
With the nation's opioid crisis, urine testing has become a booming business and is especially lucrative for doctors who operate their own labs, a Kaiser Health News investigation finds. And dozens of practitioners have earned "the lions share" of their Medicare income exclusively from urine drug screens.
At a political rally in March, President Donald Trump said drug prices are outrageous and blamed campaign contributions. Drugmakers funneled nearly $280,000 to Congress the very next day.
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trumps inauguration, which earned them entry into private events with the president and vice president.
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014.
Stay informed by signing up for the Morning Briefing and other emails:
穢 2026 KFF